Introduction to Drug Safety- Pharmacovigilance

Online Training Id: GPP-012

Credits: 6



GBP 410.00

GBP 410.00

This training course is designed to give all Health care workers involved in the supply of medicines an introduction to the fundamentals of product safety and regulatory compliance.

This training course is designed to give all Health care workers involved in the supply of medicines an introduction to the fundamentals of product safety and regulatory compliance. The interactive eLearning course on Drug safety will comprise of ;

  • Brief History of PharmacoVigilance and drug safety.
  • Differences between adverse event reporting in the clinical vs. post-marketing settings
  • How adverse events are assessed and reported
  • Relationship testing (causality)
  • Adverse event reporting formats
  • Periodic reporting

and will include case studies of adverse events to illustrate the decision-making process and reasoning needed behind when and how to properly report incidents to regulatory authorities.

Credits: 6 CPD / CME

No. of Hours: 6 hrs

Learning Objectives: 

By the end of the course you should have an understanding of regulatory requirements for drug safety, and knowledge of how to collect, assess, report and analyze adverse events.

Who Should Enroll:

Almost everyone involved in drug development and marketing needs to know the basics of FDA’s regulations regarding drug safety.  Staff who will benefit include:

  • Drug safety and pharmacovigilance
  • Regulatory affairs
  • Clinical development
  • Executives (including C-Level) with any legal responsibility for drug safety

Steve Jolley 

Steve Jolley is a subject matter expert in all areas of global safety compliance and signal detection, and is a frequent speaker at leading industry events.

Steve has 35 years’ experience in drug safety & pharmacovigilance and has worked with over 250 clients in North America, Europe, Japan, India, China, the Middle East and Africa. He holds degrees in mathematics and computer science from Cambridge University, England. He is an Adjunct Professor at Rutgers University and teaches part of their Master's degree in Drug Safety and Pharmacovigilance.

Steve is a featured speaker with FDA, EMA and MHRA at conferences and webinars on auditing, signaling and data mining. He is a member of DIA’s training faculty and is an instructor for DIA’s Clinical Safety and Pharmacovigilance Certificate Program. In 2010 Steve was elected as chairman of the DIA’s Clinical Safety and Pharmacovigilance steering committee for North America.

Steve began his career in the pharmaceutical industry in 1985 when he founded DLB Systems, a supplier of computer systems for clinical trials and adverse event reporting to many of the leading life science companies worldwide. DLB was acquired by eResearch Technologies in 1997; since then Steve has worked as an independent consultant.



Online Training Highlights
Duration: 6 hrs
Released On: 06/02/2021
Downloadable Resources: 
Need Help?

We can walk you through your program options and Subscriptions please contact us